Signios Biosciences
PrivateCompany Overview
Signios Biosciences is a biotechnology company that provides an integrated end-to-end suite of multiomic technologies and an AI-driven bioinformatics platform for pharmaceutical companies, biotech firms, and academic institutions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signios Biosciences Comparables
Compare Signios Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carolina Molecular | 85% | |
| Admera Health | 84% | |
| Psomagen, Inc. | 81% |
Signios Biosciences Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 6, 2026
Monthly visitors increased 40% MoM.
- Jul 17, 2025
Grew 17% QoQ, from 18 to 21 employees.
Signios Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Signios Biosciences's valuation, stock price, and market status.
Is Signios Biosciences a public or private company?
Signios Biosciences is a private company.
What is the current stock price of Signios Biosciences?
Signios Biosciences is a private company, so its shares have no public market price. Caplight tracks Signios Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Signios Biosciences worth (valuation)?
Valuation information for Signios Biosciences is not publicly available.
Can I buy Signios Biosciences stock?
Signios Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Signios Biosciences's last funding round?
Funding round information for Signios Biosciences is not publicly available.
Who are the main investors in Signios Biosciences?
Investor information for Signios Biosciences is not publicly disclosed.
Will Signios Biosciences IPO soon?
No public IPO plans have been announced for Signios Biosciences.
How can I track Signios Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Signios Biosciences's shares on secondary markets.